-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2016 to 2024.
- Y-mAbs Therapeutics, Inc. Current Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$752K.
- Y-mAbs Therapeutics, Inc. Current Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$146K.
- Y-mAbs Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2024 was -$146K, a 126% decline from 2023.
- Y-mAbs Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $561K, a 3017% increase from 2022.
- Y-mAbs Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $18K, a 94.1% decline from 2021.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)